KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Charles River Laboratories International (CRL) over the last 11 years, with Q3 2025 value amounting to $49.7 million.

  • Charles River Laboratories International's Shares Outstanding (Weighted Average) fell 346.09% to $49.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 346.09%. This contributed to the annual value of $51.4 million for FY2024, which is 29.87% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Shares Outstanding (Weighted Average) of $49.7 million as of Q3 2025, which was down 346.09% from $49.9 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Shares Outstanding (Weighted Average) registered a high of $51.6 million during Q2 2024, and its lowest value of $49.7 million during Q3 2025.
  • Over the past 5 years, Charles River Laboratories International's median Shares Outstanding (Weighted Average) value was $50.8 million (recorded in 2022), while the average stood at $50.8 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Shares Outstanding (Weighted Average) soared by 160.81% in 2021, and later tumbled by 346.09% in 2025.
  • Charles River Laboratories International's Shares Outstanding (Weighted Average) (Quarter) stood at $50.3 million in 2021, then grew by 1.03% to $50.8 million in 2022, then grew by 0.82% to $51.2 million in 2023, then grew by 0.3% to $51.4 million in 2024, then decreased by 3.31% to $49.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $49.7 million for Q3 2025, versus $49.9 million for Q2 2025 and $50.7 million for Q1 2025.